Vitamin D deficiency in various breast cancer subtypes and its impact on response to neoadjuvant chemotherapy in operable breast cancer

被引：0
|
作者：
Raman, R. [1 ]
Link, B. K. [1 ]
Mott, S. L. [1 ]
Schroeder, M. C. [1 ]
Thomas, A. [1 ]
机构：
[1] Univ Iowa, Iowa City, IA USA
来源：
CANCER RESEARCH | 2016年 / 76卷
关键词：
D O I：
10.1158/1538-7445.SABCS15-P5-08-48
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
P5-08-48
引用
收藏
页数：2
相关论文
共 50 条
  • [21] Predictive factors of pathological complete response by neoadjuvant chemotherapy for operable breast cancer
    Ishikawa, Takashi
    Shimizu, Daisuke
    Sasaki, Takashi
    Morita, Satoshi
    Tanabe, Mikiko
    Ota, Ikuko
    Kawachi, Kae
    Chishima, Takashi
    Ichikawa, Yasushi
    Endo, Itaru
    CANCER RESEARCH, 2011, 71
  • [22] Impact of time to surgery after neoadjuvant chemotherapy in patients with operable breast cancer
    Piacentini, F.
    Filieri, M. E.
    Grizzi, G.
    Omarini, C.
    Maur, M.
    Guaitoli, G.
    Tazzioli, G.
    Madrigali, S.
    Caggia, F.
    Luppi, G.
    ANNALS OF ONCOLOGY, 2015, 26 : 4 - 5
  • [23] Differential response from neoadjuvant chemotherapy across breast cancer subtypes
    Jinno, H.
    Matsuda, S.
    Hayashida, T.
    Takahashi, M.
    Sakata, M.
    Ikeda, T.
    Mukai, M.
    Kitagawa, Y.
    JOURNAL OF CLINICAL ONCOLOGY, 2010, 28 (15)
  • [24] Molecular subtypes as a predictor of response to neoadjuvant chemotherapy in breast cancer patients
    Shanmugam, Subbiah
    Govindasamy, Gopu
    Senthilkumar, P.
    Muniasamy, P.
    INDIAN JOURNAL OF CANCER, 2017, 54 (04) : 652 - 657
  • [25] Complete pathological response to neoadjuvant chemotherapy and its impact on breast cancer outcomes
    Boudaouara, O.
    Ben Makhlouf, W.
    Bouhamed, M.
    Graja, S.
    Charfi, S.
    Boudawara, T. Sellami
    Ben Kridis, W.
    VIRCHOWS ARCHIV, 2024, 485 : S189 - S189
  • [26] Economic evaluation of neoadjuvant chemotherapy for operable breast cancer.
    Zdenkowski, Nicholas
    D'Silva, Shefi Mary
    Lawson, Kenny
    Reeves, Penny
    Boyle, Frances M.
    JOURNAL OF CLINICAL ONCOLOGY, 2020, 38 (15)
  • [27] Results of 3 neoadjuvant chemotherapy regimens for operable breast cancer
    Ferriere, JP
    Charrier, S
    VanPraagh, I
    Cure, H
    Kwiatkowski, F
    Leduc, B
    Assier, I
    Feillel, V
    DeLatour, M
    Bay, JO
    Achard, JL
    Dauplat, J
    Chollet, P
    10TH INTERNATIONAL MEETING OF GYNAECOLOGICAL ONCOLOGY, 1997, : 383 - 388
  • [28] Neoadjuvant chemotherapy in operable breast cancer: effect on tumoral diameter
    Ruiz, C
    Barros, RA
    Nisida, A
    Rezende, W
    Pinotti, J
    BREAST, 1997, 6 (05): : P948 - P948
  • [29] PRIMARY MEDICAL (NEOADJUVANT) CHEMOTHERAPY FOR OPERABLE BREAST-CANCER
    SMITH, IE
    JONES, AL
    OBRIEN, MER
    MCKINNA, JA
    SACKS, N
    BAUM, M
    EUROPEAN JOURNAL OF CANCER, 1993, 29A (12) : 1796 - 1799
  • [30] Pathologic response pattern of breast cancer after neoadjuvant chemotherapy: its correlation with molecular subtypes
    Song, In-Hye
    Lee, Hee Jin
    Gong, Gyungyub
    CANCER RESEARCH, 2014, 74 (19)
12345